Stella Diagnostics, Inc. (SLDX)
OTCMKTS · Delayed Price · Currency is USD
0.0155
-0.0090 (-36.73%)
At close: Dec 31, 2025
Stella Diagnostics Market Cap
Stella Diagnostics has a market cap or net worth of $4.67 million as of January 23, 2026. Its market cap has decreased by -92.86% in one year.
Market Cap
4.67M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since July 7, 2008, Stella Diagnostics's market cap has increased from 15.00 to 4.67M, an increase of 31,113,246.67%. That is a compound annual growth rate of 106.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 4.67M | -72.97% |
| Dec 23, 2024 | 17.27M | 29.13% |
| Dec 29, 2023 | 13.37M | -44.17% |
| Dec 20, 2022 | 23.95M | -38.61% |
| Dec 30, 2021 | 39.02M | -11.01% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioqual | 34.44M |
| Aspira Women's Health | 19.57M |
| Longduoduo Company | 17.81M |
| Psychemedics | 10.04M |
| Interpace Biosciences | 7.66M |
| Hypha Labs | 5.91M |
| Centogene | 3.36M |
| InVitro International | 3.34M |